Výsledky vyhledávání - "Vadim Pokrovskiy"

EXPERIMENTAL STUDY OF THE EFFICACY OF L-LYSINE-A-OXIDASE TRICHODERMA CF. AUREOVIRIDE RIFAI ON MODELS OF XENOGRAFTS OF HUMAN TUMORS IN ATHYMIC MICE AND EVALUATION OF SYNERGISM WITH CISPLATIN OR TOPOISOMERASE INHIBITORS

Autor: Nikolay Chernov, Vadim Pokrovskiy, Yelena Lukasheva, Yelena Treshchalina

Publikováno v: Problems in oncology. 63:497-505

The effectiveness of L-lysine-alpha oxidase Trichoderma cf. Aureoviride Rifai BKMF-4268D (LO) on models of subcutaneous xenografts of human tumors in athymic mice as well as the effectiveness of combination therapy with known antitumor drugs: cisplat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f478099290f64597110d06930de256f5
https://doi.org/10.37469/0507-3758-2017-63-3-497-505

Zobrazit plný text záznamu

Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir

Autor: Pedro Cahn, Vadim Pokrovskiy, Praphan Phanuphak, Michael Sension, Marco Mancini, Michael Giordano, Giuseppe Pantaleo, Robert L. Murphy, Thomas Kelleher, Willy Rozenbaum, Robin Wood

Publikováno v: JAIDS Journal of Acquired Immune Deficiency Syndromes. 36:684-692

The purpose of the study was to determine long-term efficacy, safety, and tolerability of atazanavir plus stayudine/lamivudine in 346 HIV-infected patients previously treated with atazanavir or nelfinavir. BMS A1424-044 is an ongoing, multicenter, in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5df45aaa2848b088b6fde4fdbee951e
https://doi.org/10.1097/00126334-200406010-00005

Zobrazit plný text záznamu

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

Autor: Bonaventura, Clotet, Judith, Feinberg, Jan, van Lunzen, Marie-Aude, Khuong-Josses, Andrea, Antinori, Irina, Dumitru, Vadim, Pokrovskiy, Jan, Fehr, Roberto, Ortiz, Michael, Saag, Julia, Harris, Clare, Brennan, Tamio, Fujiwara, Sherene, Min, B, Young

Dolutegravir has been shown to be non-inferior to an integrase inhibitor and superior to a non-nucleoside reverse transcriptase inhibitor (NNRTI). In FLAMINGO, we compared dolutegravir with darunavir plus ritonavir in individuals naive for antiretrov

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d7f87597bb90f1512c74bb4baec182
https://doi.org/10.5167/uzh-102400

Zobrazit plný text záznamu

Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients

Autor: Vadim Pokrovskiy, Carlos M. Pérez, Mustafa A. Noor, Nestor Sosa, Eduardo Arathoon, Michael Giordano, Michael Soccodato, Alexandra Thiry, Joseph G. Jemsek, Massimo Arlotti

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 42(2)

Protease inhibitor treatment of human immunodeficiency virus (HIV)-infected individuals has been linked to the development of lipodystrophy. The effects of atazanavir on body fat distribution and related metabolic parameters were examined in antiretr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0386fb6f1c6375685ef8ac0bef01550
https://pubmed.ncbi.nlm.nih.gov/16355342

Zobrazit plný text záznamu

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV

Autor: Shannon Schrader, Asda Vibhagool, Adriano Lazzarin, Willy Rozenbaum, Jean François Delfraissy, Antonio Rivero, Kathleen Squires, William G. Powderly, Jose M. Gatell, Michael Sension, Michael Giordano, Alexandra Thiry, Joseph G. Jemsek, Vadim Pokrovskiy

Publikováno v: Journal of acquired immune deficiency syndromes (1999). 36(5)

Background: Atazanavir, an azapeptide protease inhibitor (PI), has pharmacokinetics that allow once-daily dosing, and it is not associated with significant Pl-associated dyslipidemia. Methods: A randomized, double-blind, double-dummy, active-controll

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77732d4ff771c3196350560b3a432635
https://pubmed.ncbi.nlm.nih.gov/15247553

Zobrazit plný text záznamu

HIV epidemic in Russia and neighbouring countries

Autor: Vadim Pokrovskiy

Publikováno v: Journal of the International AIDS Society

Reports of HIV/AIDS cases attributed to sexual transmission from foreigners were published in the USSR in the mid of 80s. In the initial decade of the epidemic, the subtype B was found in men who have sex with men (MSM) population and several non-B s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337b9d62f7fef0d6d1d0920ac1557be9
https://doi.org/10.7448/ias.17.4.19502

Zobrazit plný text záznamu

Plasmacytoid Dendritic cells (pDCs) in HIV-infected and HIV/HCV-co-infected patients receiving successful treatment

Autor: Vadim Pokrovskiy, Olga Khokhlova, Lidya Serebrovskaya, Ara Reizis, Natalia Gerasimova

Publikováno v: Journal of the International AIDS Society

Introduction : Depletion of cellular pool and constant activation of plasmacytoid dendritic cells (pDCs) in HIV-infected persons (HIV+) are associated with disease progression and manifestation of opportunistic infections. The influence of highly-act

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726a5c068bed6d636f7a2eb2dd8e91c3
https://doi.org/10.7448/ias.17.4.19642

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání